The Italian study showed that patients with HCC resulting from viral infections or fatty liver had significantly higher ...

Using a novel stem cell platform, a team of MUSC researchers has identified a pathway that could be targeted by drugs to ...

Nonalcoholic fatty liver disease (NAFLD ... and end-stage liver disease. Hepatocellular carcinoma (HCC) is a documented complication in an as yet unknown percentage of cases of NASH cirrhosis.

One liver cancer, hepatocellular carcinoma (HCC), is associated ... Both CLD subtypes showed lower gene expression associated with fatty acid metabolism, and Subtype 2 showed higher fatty acid ...

Fatty acid (FA) reprogramming has a significant role in liver cancer. However, the contribution of FA metabolism ...

Systemic therapy represents the standard of care treatment for patients with advanced hepatocellular carcinoma (HCC). Given ...

Background: Hepatoblastoma (HBL) and hepatocellular carcinoma (HCC) are respectively the first and the second most common pediatric malignant liver tumors. The purpose of this study was to ...

The FDA approved nivolumab and ipilimumab for unresectable or metastatic hepatocellular carcinoma, a prevalent and deadly liver cancer in the U.S. CHECKMATE-9DW trial results showed improved ...